Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Phase II Dose-Ranging Study of the OrthoDerm Transdermal Nitroglycerin Patch for Patients With Chronic Lateral Epicondylitis

NCT00447928 is registered in ClinicalTrials.gov with Cure Therapeutics as lead sponsor.

NCT NCT00447928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00447928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled Phase II Dose-Ranging Study of the OrthoDerm Transdermal Nitroglycerin Patch for Patients With Chronic Lateral Epicondylitis
Lead sponsor
Cure Therapeutics
Phase
Phase 2
Overall status
Unknown status
Start date
April 30, 2007
Completion date
November 30, 2007
Enrollment
164
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tendonitis